<p>Adverse events which occurred in at least 5% of patients in any arm of the two clinical efficacy trials and the open trial are listed below by treatment group. These adverse events should be considered by the physician when prescribing Megestrol Acetate. Those are- diarrhea, impotence, rash, flatulence, hypertension, asthenia, insomnia, nausea, anaemia, fever, libido decreased, dyspepsia, hyperglycemia, headache, vomiting, pneumonia &amp; urinary frequency.<br />
<br />
Adverse events which occurred in 1% to 3% of all patients enrolled in the two clinical efficacy trials with at least one follow-up visit during the first 12 weeks of the study are listed below by body system.</p>

<ul>
	<li>Body as a Whole: abdominal pain, chest pain, infection, candidiasis and sarcoma</li>
	<li>Cardiovascular System: cardiomyopathy and palpitation</li>
	<li>Digestive System: constipation, dry mouth, hepatomegaly &amp; increased salivation</li>
	<li>Hemic and Lymphatic System: leukopenia</li>
	<li>Metabolic and Nutritional: LDH increased, oedema and peripheral oedema</li>
	<li>Nervous System: paresthesia, confusion, convulsion, depression, neuropathy, hypesthesia and abnormal thinking</li>
	<li>Respiratory System: dyspnea, cough and lung disorder</li>
	<li>Skin and Appendages: alopecia, herpes, pruritus, vesiculobullous rash, sweating and skin disorder</li>
	<li>Urogenital System: albuminuria, urinary incontinence, urinary tract infection and gynecomastia</li>
</ul>